- Home
- VNRX vs XOS Comparison
VNRX vs XOS Comparison
Compare VNRX & XOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VNRX | XOS |
|---|---|---|
| Founded | N/A | 2016 |
| Country | United States | United States |
| Employees | N/A | 101 |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Construction/Ag Equipment/Trucks |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.5M | 22.8M |
| IPO Year | 2012 | N/A |
Fundamental Metrics
Financial Performance| Metric | VNRX | XOS |
|---|---|---|
| Price | $2.73 | $2.29 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 1 |
| Target Price | $1.67 | ★ $7.00 |
| AVG Volume (30 Days) | ★ 276.1K | 184.0K |
| Earning Date | 05-12-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,727,384.00 | N/A |
| Revenue This Year | $355.66 | $29.02 |
| Revenue Next Year | $849.08 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 40.04 | N/A |
| 52 Week Low | $0.13 | $1.60 |
| 52 Week High | $3.26 | $5.60 |
Technical Indicators
Market Signals| Indicator | VNRX | XOS |
|---|---|---|
| Relative Strength Index (RSI) | 65.78 | 67.50 |
| Support Level | $0.22 | $2.11 |
| Resistance Level | $2.89 | $2.60 |
| Average True Range (ATR) | 0.29 | 0.20 |
| MACD | -0.02 | 0.03 |
| Stochastic Oscillator | 64.18 | 81.91 |
Price Performance
Historical ComparisonAbout VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on diagnostics and monitoring.
About XOS Xos Inc.
Xos Inc is a fleet electrification solutions provider committed to the decarbonization of commercial transportation. Xos designs and manufactures Class 5 through 8 battery-electric commercial vehicles that travel on last-mile, back-to-base routes of up to 200 miles per day. Xos also offers charging infrastructure products and services through Xos Energy Solutions to support electric vehicle fleets. Its products include Stepvan, MDXT, HDXT, Xosphere, and Xos Energy Solutions.